Six months on semaglutide, four months since switching to tirz, and the GI profiles are genuinely different in ways I didn’t expect going in. Worth laying out what I observed, because most of what gets written lumps all GLP-1 side effects together as if the mechanism doesn’t matter. On sema, my dominant issue was nausea, mostly in the first 48 hours post-injection, occasionally some loose stools. Unpleasant but manageable. On tirz, the nausea was much milder from the start, but constipation became the real problem by week three. Not uncomfortable bloating, actual transit slowdown. Four to five days between movements at points, which I hadn’t experienced since perimenopause. The pharmacology here is worth understanding. Tirz hits both GLP-1 and GIP receptors. GIP receptors are expressed throughout the GI tract and appear to slow motility more than GLP-1 alone does. Sema is selective for GLP-1, which tends to produce nausea and urgency rather than slowing. That’s a real mechanistic distinction, not just individual variation. There’s also a menopause layer that I don’t see discussed much. Estrogen has measurable effects on gut motility, and post-menopausal women have slower baseline transit than premenopausal women of the same age. I’ve been on transdermal estradiol for three years, which probably helps, but even so I suspect women in our cohort are more susceptible to the constipation side of the GIP profile than the average trial participant. What helped practically: 400mg magnesium glycinate at night, increased fluid intake to at least 2.5 litres daily, and tracking bowel frequency against injection day in a symptom log. The pattern clarified quickly once I was logging it rather than guessing from memory. If you’re switching from sema to tirz expecting the same GI experience, go in prepared for a different profile rather than a milder version of the same thing
the menopause layer point is the one that gets me, bc I genuinely don’t see it discussed and it probably explains why a lot of women in peri or post report worse tirz constipation than the trial data would predict. estrogen’s effect on GI motility is real and the trial populations weren’t always well-stratified by HRT status. one thing I’d add: the 400mg mag glycinate intervention is solid, but the timing relative to injection day matters more than I expected. days 3-5 post-dose were my worst transit window, so front-loading the mag the night before injection day instead of just nightly-as-habit actually smoothed things out a bit. anecdotal, but once I started logging injection day vs bowel frequency the correlation was obvious in a way it wasn’t from memory. the part I’d slightly push back on is framing GIP motility slowing as a clear mechanistic distinction vs individual variation. the receptor expression data is there but the clinical magnitude seems to vary a lot person to person, which suggests there’s something else modifying the effect, maybe baseline transit speed, fiber intake, whatever. the mechanism is real, the effect size probably isn’t uniform. doesn’t change the practical advice, just worth noting if someone switches to tirz and has zero constipation and wonders if they’re doing it wrong.
The front-loading timing point is useful and I’m going to test it. My current habit is just nightly-as-habit, which means I’m probably under-supplemented exactly when motility is slowest. On the GIP effect size variation: the pushback is fair, but I’d frame it slightly differently. The mechanism being real doesn’t mean the clinical expression is uniform, and those aren’t in conflict. What I’d want to know is whether baseline transit time predicts constipation severity on tirz better than fiber intake does, bc that would actually tell you something actionable before you start the medication.
magnesium glycinate 400 feels like managing the symptom rather than treating the actual problem. for real transit slowdown past week three, ime osmotic agents (citrate or miralax) plus the mag handle it way better than mag alone. imo your GIP mechanistic case is solid, but four to five day cycles usually mean you need something that actually moves stool, not just supplementation. ymmv obviously, but i’d escalate if that were me
anyway.
baseline transit time as a predictor is the right question to ask, but I’d bet against it being cleaner than fiber intake in practice. the issue is baseline transit isn’t a stable single number for most women our age, it shifts with cycle phase if you’re still cycling, with hydration, with stress, with whether you’ve travelled that week. fiber intake is messier as a variable but at least it’s something you can actually measure and modify in advance. what would actually be useful is a short pre-tirz transit log over two or three weeks, averaged, paired against a fiber baseline. one snapshot won’t tell you much.